Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Relay Therapeutics Inc (NQ: RLAY ) 7.460 +0.060 (+0.81%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 3,463,947 Open 7.510 Bid (Size) 7.250 (1) Ask (Size) 7.710 (1) Prev. Close 7.400 Today's Range 7.363 - 7.622 52wk Range 5.700 - 12.14 Shares Outstanding 121,613,181 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week September 15, 2024 The AI-powered drug discovery process is expected to grow by a CAGR of 30% between now and 2030 which should result in as many as 50 novel therapies being brought to market by then and generate annual... Via Talk Markets Why Relay Therapeutics Plummeted by Nearly 14% Today September 11, 2024 Investors weren't happy with the company's latest effort at capital-raising. Via The Motley Fool Performance YTD -37.07% -37.07% 1 Month +4.48% +4.48% 3 Month +18.41% +18.41% 6 Month -10.12% -10.12% 1 Year -9.69% -9.69% More News Read More Why Relay Therapeutics (RLAY) Stock Is Down 17% Today September 11, 2024 Via Benzinga This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday September 11, 2024 Via Benzinga GameStop Reports Weak Sales, Joins Petco, Relay Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session September 11, 2024 Via Benzinga Expert Ratings For Relay Therapeutics August 07, 2024 Via Benzinga Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket September 11, 2024 Via Benzinga Relay Therapeutics Announces Pricing of Public Offering of Common Stock September 10, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market September 10, 2024 Via Benzinga AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th September 10, 2024 Via Talk Markets This Johnson Controls International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday September 10, 2024 Via Benzinga Dow Jumps Over 1% Following Last Week's Selloff: Investor Sentiment Improves, But Fear & Greed Index Remains In 'Fear' Zone September 10, 2024 Via Benzinga Topics Stocks Exposures US Equities Relay Therapeutics Announces Proposed Public Offering of Common Stock September 09, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher September 09, 2024 Via Benzinga Exposures Fossil Fuels Nasdaq Surges Over 1%; US Wholesale Inventories Rise 0.2% In July September 09, 2024 Via Benzinga Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients September 09, 2024 Via Benzinga Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday September 09, 2024 Via Benzinga US Stocks Higher; Dow Surges Over 200 Points September 09, 2024 Via Benzinga Topics Stocks Exposures US Equities Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival September 09, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024 September 06, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone! September 05, 2024 Via Talk Markets Topics Economy Exposures Economy Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week August 27, 2024 Via Talk Markets RLAY Stock Earnings: Relay Therapeutics Beats EPS for Q2 2024 August 06, 2024 Via InvestorPlace Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights August 06, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024 July 30, 2024 From Relay Therapeutics, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
